Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: attendant (5), associated (647), connected (209), affiliated (11), related (736), simultaneous (13)

Cisplatin (40)-Radiotherapy

Description: Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN (40) RT Regimen Head and Neck Cancer – Cisplatin (40) RT Indication Radical treatment of locally ad
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Cisplatin40-Radiotherapy.pdf

NilotinibChronic

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (chronic phase) Regimen • CML – Nilotinib (chronic phase) Indication • As an option for the treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibChronic.pdf

NilotinibAccelerated

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (accelerated phase) Regimen • CML – Nilotinib (accelerated phase) Indication • Nilotinib is an option
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibAccelerated.pdf

ImatinibChronic

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (chronic phase) • CML – Imatinib (chronic phase) Indication • As the pref
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibChronic.pdf

ImatinibAccelerated

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (accelerated phase) • CML - Imatinib (accelerated phase) Indication • As
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibAccelerated.pdf

Hydroxycarbamide

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia (CML) Hydroxycarbamide Regimen • CML - Hydroxycarbamide Indication • Chronic or accelerated phase chronic m
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Hydroxycarbamide.pdf

Cetuximab (14 day)

Description: Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB (14 day) This regimen may require funding Regimen • Colorectal Cancer – C
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab14day.pdf

Temozolomide RT (7 day)

Description: Chemotherapy Protocol Central Nervous System TEMOZOLOMIDE RT (7 day) Regimen • CNS – Temozolomide RT (7 day) Indication • First line treatme
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Temozolomide-RT-7-day.pdf

InP IVE-Epirubicin-Etoposide-Ifosfamide Ver1.1

Description: Chemotherapy Protocol LYMPHOMA EPIRUBICIN-ETOPOSIDE-IFOSFAMIDE (IVE) Inpatient Regimen Regimen • Lymphoma – InP-IVE-Epirubicin-Etoposide-Ifosfamide Indication • Non Hod
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-IVE-Epirubicin-Etoposide-Ifosfamide.pdf

InP-Cisplatin-Etoposide-Ifosfamide (VIP)

Description: Chemotherapy Protocol GERM CELL CISPLATIN-ETOPOSIDE-IFOSFAMIDE (VIP) Inpatient Regimen Regimen • Germ Cell – InP-Cisplatin-Etoposide-Ifosfamide (VIP) Indication • Metas
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/InP-Cisplatin-Etoposide-Ifosfamide-VIP.pdf

21 to 30 of 73

Previous 1 2 3 4 5 … Next